SOAT1 and breast carcinoma: Using a cisplatin (DDP)-resistant breast cancer cell line MCF-7/DDP, miR-210 downregulation reduced the chemoresistance potential and increased apoptosis by targeting the JAK/STAT signaling pathway [67].